Page last updated: 2024-11-08

trifluoromethionine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

trifluoro-L-methionine : An L-alpha-amino acid, methionine, with the S-methyl group trifluoro-substituted. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID165196
CHEBI ID43978
SCHEMBL ID245986
MeSH IDM0113743

Synonyms (28)

Synonym
2-amino-4-trifluoromethylsulfanyl-butyric acid
mf3 ,
trifluoromethionine ,
DB03799
trifluoro-l-methionine
4220-05-7
(2s)-2-amino-4-(trifluoromethylsulfanyl)butanoic acid
764-52-3
dl-homocysteine, s-(trifluoromethyl)-
CHEBI:43978
SCHEMBL245986
(trifluoromethyl)homocysteine #
mfcd07636752
trifluoromethionine (h-l-met(f3)-oh)
AKOS027393884
(2s)-2-amino-4-[(trifluoromethyl)sulfanyl]butanoic acid
(s)-2-amino-4-((trifluoromethyl)thio)butanoic acid
AS-62629
Q27094689
C76445
DTXSID10962362
l-homocysteine, s-(trifluoromethyl)-
QH3U5JK2DR ,
(s)-2-amino-4-((trifluoromethyl)thio)butanoicacid
unii-qh3u5jk2dr
EN300-761541
s-(trifluoromethyl)-l-homocysteine
c5h8f3no2s

Research Excerpts

Overview

Trifluoromethionine (TFM) is a promising lead compound for antiamoebic drugs.

ExcerptReferenceRelevance
"Trifluoromethionine (TFM) is a promising lead compound for antiamoebic drugs."( Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica.
Ali, V; Kobayashi, S; Nozaki, T; Sato, D; Shibata, N; Soga, T; Suematsu, M; Takeuchi, T; Tokoro, G; Toru, T; Yamamoto, M; Yasui, H, 2010
)
1.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
L-methionine derivativeA proteinogenic amino acid derivative resulting from reaction of L-methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-methionine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's3 (15.79)18.2507
2000's8 (42.11)29.6817
2010's7 (36.84)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.17 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]